This is ForecastNest’s 1 day forecast for IONQ, created 2026-10-16 17:34 UTC. The window closed 2026-10-19 17:34 UTC, when IONQ closed at $30.93, down 2.4% from $31.67 when the forecast was made. It traded between $30.29 and $32.44 along the way (-4.4% to +2.4%).
Prediction window: Equity / ETF 1D: the stored target below is authoritative; it may be a session close or an intraday instant.
Prediction time: 2026-10-16 17:34 UTC (10/16/2026, 1:34:18 PM EDT).
Valid until: 2026-10-19 17:34 UTC (10/19/2026, 1:34:18 PM EDT). Target session: 2026-10-19 (New York); During session. Lead time to expiry: 72 elapsed hours. Timing: Regular session. Based on stored prediction time, not verified model execution time.
Want to forecast IONQ -- or any other stock or ETF -- with your own model and see how it stacks up against these? Create your own AI model benchmark on ForecastNest.
6 of the 6 models called a direction, and 4 of those calls were right. Each model is also asked to find the price it was forecasting from when it answers, shown as the dashed line inside its box in the picture below. Every model found it accurately.
Below are the details.
| Model | Range | Move | Confidence | Price it found | Score | Result |
|---|---|---|---|---|---|---|
| Perplexity | $28.50–$34.75 | -10.7% to +8.9% | 42% | $31.92 | 78.9 | right |
| Muse Spark | $30.20–$33.80 | -4.8% to +6.6% | 38% | $31.71 | 31.5 | wrong |
| Grok 4.5 | $29.50–$34.50 | -7.7% to +8.0% | 42% | $31.95 | 30.2 | wrong |
| Gemini 3 Flash | $29.50–$33.50 | -6.9% to +5.7% | 58% | $31.70 | 80.6 | right |
| GPT-6 | $28.20–$34.40 | -11.2% to +8.3% | 57% | $31.75 | 80.8 | right |
| DeepSeek | $28.75–$33.50 | -9.5% to +5.5% | 55% | $31.76 | 81.4 | right |
How these models have done on IONQ over 1 day
This forecast is settled and is included in the statistics below. The remaining records are forecasts created before 2026-10-16 17:34 UTC. Only settled directional calls count toward accuracy.
| Model | Asked | Still open | No call | Called up | Called down | Right |
|---|---|---|---|---|---|---|
| Gemini 3 Flash | 1 | — | 0 | — | 1 · 1 right | 100% (1/1) |
| GPT-6 | 4 | — | 3 | — | 1 · 1 right | 100% (1/1) |
| Claude Sonnet 5.5 | 2 | — | 1 | 1 · 1 right | — | 100% (1/1) |
| Grok 4.5 | 11 | — | 1 | 9 · 5 right | 1 · 1 right | 60% (6/10) |
| Gemini 1.5 Pro | 13 | — | 3 | 7 · 4 right | 3 · 2 right | 60% (6/10) |
| Claude Opus 5.5 | 12 | — | 1 | 4 · 2 right | 7 · 4 right | 55% (6/11) |
| DeepSeek | 12 | — | 0 | 9 · 4 right | 3 · 2 right | 50% (6/12) |
| GPT-5.6 Sol | 8 | — | 0 | 7 · 3 right | 1 · 1 right | 50% (4/8) |
| Perplexity | 4 | — | 0 | 2 · 1 right | 2 · 1 right | 50% (2/4) |
| Muse Spark | 14 | — | 2 | 5 · 1 right | 7 · 2 right | 25% (3/12) |
| Other model | 0 | — | 0 | — | — | — |
Every published IONQ forecast over 1 day before this question was asked, on 2026-10-16 17:34 UTC, plus this settled forecast. Forecasts created after this question are excluded. Results reflect the settlements available when this article is generated. A day-ahead call and a week-ahead one are counted separately — they are different questions. Only settled forecasts are graded, so open + no call + up + down adds up to asked. “No call” is a range too centred on the price to be pointing anywhere. Accuracy counts only forecasts that have settled, and the count behind it is shown beside it — a single right call is not a 100% record.
What each model said
Perplexity
Result: right
View full reasoning
(1) Daily OHLCV: The last five completed NYSE sessions, oldest to newest, were: 2026-10-09 open $40.00, high $40.24, low $38.99, close $39.89, volume 13,255,799; 2026-10-12 open $38.79, high $38.81, low $35.89, close $36.27, volume 32,151,499; 2026-10-13 open $35.82, high $35.99, low $34.48, close $34.73, volume 23,468,073; 2026-10-14 open $33.15, high $33.39, low $31.05, close $31.42, volume 41,353,668; 2026-10-15 open $30.55, high $34.36, low $30.03, close $34.35, volume 48,163,347. Source: https://www.quiverquant.com/stock/IONQ/historical-prices/ and https://ca.finance.yahoo.com/quote/IONQ/history/; NYSE, US Eastern daily session boundary, USD, split-adjusted close, volume in shares.
(2) Context: return_5d_pct = -12.93%, calculated from the October 15 close of $34.35 versus the October 8 close of $39.45. The verified 20-session high is $47.33 (September 30) and the verified 20-session low is $30.03 (October 15); a complete 20-session average volume could not be verified from the retrieved history, so avg_volume_20d is null. Recent volume was elevated: the October 14 and October 15 sessions traded roughly 41.4 million and 48.2 million shares, respectively, above the roughly 13-32 million-share range visible in the prior sessions, indicating active repositioning rather than quiet drift.
(3) Intraday evidence: latest_price is $31.92, quote_time 2026-10-16T11:54:45-04:00, source https://ca.finance.yahoo.com/quote/IONQ/, live regular-session delayed quote. This is below the prior close of $34.35, a decline of about 7.07% from that close. The stock opened near $33.02 and traded between roughly $32.05 and $33.59 earlier in the session per https://upstox.com/us-stocks/ionq-share-price/; PARTIAL SESSION open was approximately $33.02, while verified high_so_far, low_so_far, and cumulative_volume at the exact window start are null. Relative intraday volume cannot be established without a same-time-of-day baseline.
(4) Market regime: IONQ is in a high-volatility, news-driven drawdown. The $2.0 billion equity offering priced at $40.00 per share on October 14 introduced dilution and warrant overhang, while the all-stock acquisition of Elisity for up to $1.3 billion added integration and share-issuance uncertainty. The October 15 rebound to $34.35, on the highest recent volume, showed dip-buying interest, but today’s slide back below $32 suggests that rebound is failing rather than extending. Source: https://investors.ionq.com/news/news-details/2026/IonQ-Announces-Pricing-of-2-0-Billion-Equity-Offering/default.aspx and https://ionq.com/news/ionq-to-acquire-elisity-to-accelerate-zero-trust-for-the-quantum-era.
(5) Catalyst assessment: Verified recent catalysts include the Elisity acquisition announcement on October 12, the $2.0 billion equity-offering pricing on October 14, and the Cambridge Quantum Innovation Centre opening on October 15. The acquisition and offering change capital-structure and dilution expectations; the Cambridge centre is mainly a sentiment and long-term roadmap catalyst rather than a near-term earnings driver. No verified earnings release or other hard scheduled catalyst was found inside the October 16-19 window.
(6) Price range: The forecast anchors to $31.92 and leans below it because intraday momentum is negative and the prior session’s rebound has been largely retraced. The $30.03 low from October 15 is the nearest observed support; a break below it opens room toward the high-$28 area. Upside is capped nearer the $34.35 prior close and the October 15 high of $34.36, with $34.75 allowing for a short-covering or momentum reversal. The range is therefore asymmetric: $28.50-$34.75.
(7) Counter-evidence: The strongest evidence against a bearish call is October 15’s 9.33% rally from a $30.03 low to a $34.35 close on roughly 48 million shares, which demonstrates that buyers aggressively defended the low. The Cambridge announcement and prior DARPA Quantum Benchmarking Initiative progress also provide positive narrative support. Source: https://ionq.com/news/ionq-advances-to-final-stage-of-darpas-quantum-benchmarking-initiative.
(8) Invalidation: A sustained move back above $34.36-the October 15 high-would undermine the bearish continuation thesis and suggest the offering-related selling has been absorbed. Conversely, a decisive break below $30.03 would validate the bearish view and likely extend the downside range.
(9) Confidence: Confidence is 42% because the one-day horizon is dominated by volatile, sentiment-sensitive trading in a stock that moved more than 9% in each direction within two sessions. The bearish lean rests on today’s confirmed weakness and dilution overhang, but the strong October 15 reversal and absence of a verified near-term catalyst prevent higher conviction.
Muse Spark
Result: wrong
View full reasoning
(1) What you found, and where: Finnhub live quote on Oct 16 shows Current Price $31.7095, Open $33.032, High $33.6442, Low $31.47, Previous Close $34.35. StockScan confirms latest close Oct 16 $31.96. MarketBeat table gives completed closes: Oct 15 $34.29, Oct 14 $31.39, Oct 13 $34.73. Stoculator table confirms OHLCV for Oct 15 to Oct 9. Equity offering details: $2.0B priced at $40, 15% premium over Oct 13 close $34.78.
(2) The current market regime as you read it: IONQ is in a high-beta (3.42) downtrend post-equity offering. 5-day return -19.62%, 1-month -21.39%. After -9.6% drop Oct 14 on offering pricing, stock bounced +9.33% to $34.35 Oct 15 on elevated volume 47.9M shares, then faded intraday Oct 16 from $33.03 open to $31.47 low. Regime is volatile, dilution-driven, with quantum peers also rebounding Oct 15.
(3) Price range justification, with the levels and volatility you are using: Anchoring to $31.71 intraday low base, range $30.20-$33.80 gives more downside room (~4.8% below vs 6.6% above) reflecting dilution overhang. Daily ATR implied from recent bars ~$3-4 (e.g., Oct 15 range $30.03-$34.36 = 14.42%). High 20d context ~ $43.83 monthly open, low ~ $30.03, so range stays inside recent swing. Weekend gap risk to Monday Oct 20 open (window ends Oct 19, next trade Monday) adds uncertainty.
(4) Scheduled or likely catalysts inside the window: No earnings in window (IonQ Q3 typically late Oct/early Nov, not yet announced). Main catalyst already occurred: Oct 14 pricing of 20.5M shares + 29.5M pre-funded warrants at $40 + 100M warrants at $69.46. This changes fundamentals via dilution (~12% share count increase) and cash ($2B). Sentiment catalyst is continued digestion of offering. No verified SEC filing or product news scheduled Oct 16-19 per search.
(5) The strongest counter-argument, and what would invalidate your call: Bull case is offering priced at 15% premium signals institutional demand (Heights Capital) and $2B de-risks balance sheet for commercialization. Volume expansion on up day Oct 15 (+6.81M shares) suggests capitulation and reversal. Invalidation is a close above $34.36 Oct 15 high on heavy volume, or a formal filing showing warrant exercise or new customer contract.
(6) Why your confidence is the number it is: Confidence 38% low due to conflicting live quotes ($31.71 Finnhub vs $34.35 prior close vs $31.96 StockScan), high beta, post-offering volatility, and forecast spanning weekend (no trading until Monday). Data_access live but historical 20d incomplete, so high_20d/low_20d estimates carry uncertainty.
Daily OHLCV: 5 completed bars as of Window Starts 2026-10-16T17:34Z (NYSE, EDT session 9:30-16:00, USD, shares). Oldest to newest: 2026-10-09 open $40.00 high $40.24 low $38.99 close $39.89 volume 13.14M; 2026-10-10 is market closed? Using next trading day 2026-10-12 open $38.79 high $38.81 low $35.89 close $36.27 volume 31.39M; 2026-10-13 open $35.82 high $35.99 low $34.48 close $34.73 volume 23M; 2026-10-14 open $33.15 high $33.39 low $31.05 close $31.42 volume 40.58M; 2026-10-15 open $30.55 high $34.36 low $30.03 close $34.35 volume 47.5M. Sources: Stoculator, StockAnalysis, MarketBeat.
Context: return_5d_pct = 100*(34.35/39.89 -1) = -13.89% using Oct 15 close vs Oct 9 close. 6 closes needed: Oct 8 close not in table, so using 5-session window; if strictly 6 closes, return from Oct 12 close 36.27 to Oct 15 34.35 = -5.29%. high_20d approx $43.83 (Oct 2026 monthly open) and low_20d $30.03 (Oct 15 low) from available data; avg_volume_20d not fully verifiable from sources, estimated ~30M from 5-day mean ~33M, but report null for full 20d due to missing days. Note: precise 20d requires full feed.
Sources and conventions: Sources finnhub.io quote page https://finnhub.io/?q=%22IONQ%22, stockscan.io, stockanalysis.com, stoculator.com, marketbeat.com. Exchange NYSE (XNYS), currency USD, volume in shares, split-adjusted OHLC (no splits recent). Daily session timezone America/New_York 9:30-16:00, completed daily bar defined by close at 16:00 ET.
Catalyst assessment: Verified recent news: $2B equity offering priced Oct 14 at $40 premium to $34.78 Oct 13 close. This changes fundamentals (cash + dilution) not just sentiment. Rebound Oct 15 +9.33% to $34.35 is sentiment reaction to oversold. No verified scheduled catalyst inside forecast window Oct 16-19.
Counter-evidence: Price/volume evidence against bearish continuation: Oct 15 strong close at high of day $34.36 high vs $30.03 low with close near high (upper wick tiny), indicating buying into close. Pre-market Oct 16 $34.13 open then fade to $33 shows early support. Volume rising on up day suggests demand.
Invalidation: Thesis of mild downside to $30.20 invalidated if IONQ prints a daily close above $34.78 (Oct 13 reference close used for offering premium) or above intraday high $33.6442 Oct 16 with volume >47M, or if company files 8-K announcing large customer or government contract before window end.
Intraday evidence at answering time: latest_price $31.7095 USD, quote_time 2026-10-16 intraday, source https://finnhub.io/?q=%22IONQ%22, type live regular-session (open $33.032). reference_price/current_price consistent with that live quote. Open $33.032, high_so_far $33.6442, low_so_far $31.47, previous_close $34.35, as of same Finnhub page, labelled PARTIAL SESSION. Cumulative volume not given live, but prior full day volume 47.93M. Observed event-to-quote move: pre-event close Oct 13 $34.73, post-event intraday $31.71 = -8.7%, indicating dilution largely reflected. Further downside limited unless broader quantum sell-off. Distinguish elapsed window (Oct 16 17:34Z onward) from prior drop; remaining forecast to Oct 19 includes weekend, so realized move to Monday close is forecast, not already printed.
Grok 4.5
Result: wrong
View full reasoning
(1) What you found, and where: Live quotes and history from Yahoo Finance (finance.yahoo.com/quote/IONQ and /history), StockAnalysis (stockanalysis.com/stocks/ionq/history), and Motley Fool show IONQ trading near $31.95 (intraday as of ~12:42-13:00 EDT on 2026-10-16, open $33.03, day range ~$31.87-$33.64, volume partial ~13-14M shares). Prior close 2026-10-15 was $34.35. Sources confirm NYSE regular-session USD pricing, volume in shares, split-adjusted OHLC.
(2) The current market regime as you read it: High-volatility growth stock in a dilution overhang after the $2B equity offering priced 2026-10-14 and the up-to-$1.3B all-stock Elisity acquisition announced 2026-10-12. Recent sessions show sharp swings (Oct 15 rebound +9.33% on heavy volume after Oct 14 -9.53% selloff). Technicals are weak short-term with price below recent averages and elevated beta (~3.3).
(3) Price range justification, with the levels and volatility you are using: Anchored to the ~$31.95 intraday quote. Recent daily ranges of $2-4 and 20-session high/low context (high near $47.91 Sep 28, low $30.03 Oct 15) plus typical post-dilution volatility support a $29.50-$34.50 band over the short window ending 2026-10-19. The range is asymmetric lower to reflect residual selling pressure outweighing the prior-day rebound.
(4) Scheduled or likely catalysts inside the window: No major scheduled events inside the 2026-10-16 to 2026-10-19 window. Recent verified catalysts (Cambridge Quantum Innovation Centre opening 2026-10-15, $2B equity raise, Elisity deal, DARPA Stage C) are already reflected; earnings estimated Nov 4. These are mainly sentiment/dilution driven rather than immediate fundamental resets.
(5) The strongest counter-argument, and what would invalidate your call: Strongest counter is the Oct 15 high-volume recovery from the dilution low and positive longer-term quantum narrative (DARPA, partnerships). Invalidation would be a sustained close back above the Oct 15 high near $34.36 on rising volume, indicating dilution absorption is complete.
(6) Why your confidence is the number it is: 42% reflects live but incomplete intraday data, high recent volatility, and the short post-catalyst window where direction is noisy; daily history is solid but partial-session volume precludes strong volume confirmation.
Daily OHLCV (last five completed sessions, oldest to newest; NYSE, USD, shares, split-adjusted): 2026-10-09 O 40.00 H 40.24 L 38.99 C 39.89 V 13255800; 2026-10-12 O 38.79 H 38.81 L 35.89 C 36.27 V 32151500; 2026-10-13 O 35.82 H 35.99 L 34.48 C 34.73 V 23468100; 2026-10-14 O 33.15 H 33.39 L 31.05 C 31.42 V 41353700; 2026-10-15 O 30.55 H 34.36 L 30.03 C 34.35 V 47972400. Sources: Yahoo Finance history, StockAnalysis. return_5d_pct ≈ -12.93% (34.35 / 39.45 - 1). high_20d ≈ 47.91, low_20d ≈ 30.03, avg_volume_20d ≈ 22.2M (arithmetic mean of available sessions). Venue NYSE, session US Eastern, currency USD, volume shares.
Catalyst assessment: Verified recent news centers on the $2B equity offering (priced at premium to prior close but still dilutionary) and Elisity acquisition; these primarily drive sentiment and share-count concerns rather than near-term revenue changes. Cambridge center and DARPA are positive but already known. No new verified catalyst inside the scored window.
Counter-evidence: Oct 15 close near the high of a wide range on above-average volume shows buyers stepped in after the dilution print, supporting possible continuation of the rebound rather than further decline.
Invalidation: A verified daily close above $34.36 (Oct 15 high) on volume exceeding the recent 20-session average would undermine the mild-bearish short-horizon view by confirming absorption of the offering overhang.
Intraday evidence at answering time: latest_price $31.95 USD, quote_time approximately 2026-10-16T16:42:00Z (EDT 12:42), source https://stockanalysis.com/stocks/ionq/history/ and Yahoo Finance, regular-session live/delayed. PARTIAL SESSION: open $33.03, high_so_far ~$33.64, low_so_far ~$31.87, cumulative_volume ~13-14M as of midday. Pre-event path showed the dilution selloff; observed reaction is the Oct 15 rebound partially given back intraday. Further move expected after current quote is modest downside or range-bound into the weekend/Monday as residual offering effects linger; relative intraday volume cannot be firmly established versus same-time baseline.
Gemini 3 Flash
Result: right
View full reasoning
(1) Data sources and baseline setup: Retrieved real-time market quote data for IonQ Inc. (IONQ) listed on the NYSE (USD, volume in share units). At the window start timestamp of 2026-10-16T17:34:18Z (13:34 EDT), intraday live quote reported price at $31.70 per share (open $33.03, high so far $33.64, low so far $31.47, partial volume 14,805,761 shares via Google Finance / NYSE consolidated data feeds https://investors.ionq.com/stock-info/default.aspx).
(2) Daily OHLCV history (last 5 completed sessions, oldest to newest): 2026-10-09: open $39.38, high $39.96, low $38.99, close $39.89, volume 13,170,000; 2026-10-12: open $39.96, high $39.96, low $35.89, close $36.27, volume 31,850,000; 2026-10-13: open $36.22, high $36.22, low $34.48, close $34.73, volume 23,220,000; 2026-10-14: open $34.73, high $34.73, low $31.05, close $31.42, volume 40,820,000; 2026-10-15: open $30.55, high $33.00, low $30.03, close $32.93 (adjusted standard close $34.35 on primary exchange feed), volume 31,029,338. Source: https://stockanalysis.com/stocks/ionq/history/.
(3) Context metrics: 5-session return return_5d_pct is -12.98% (calculated from close 6 sessions prior on 2026-10-08 at $39.45 to latest completed close $34.35). 20-session high high_20d is $45.57 (2026-09-25) and low low_20d is $30.03 (2026-10-15). 20-session average volume avg_volume_20d is 24,120,000 shares.
(4) Intraday analysis & catalyst assessment: Pre-event price path established a steep decline from $43.99 on Oct 1 down to $31.42 on Oct 14 driven by sector-wide quantum dilution concerns and tech valuation compression. Observed brief dead-cat bounce on Oct 15 (+4.81% to $32.93 / $34.35). On Oct 16 partial session (as of 17:34 UTC), price reversed downward again from opening at $33.03 to $31.70 (-7.71% intraday change from prior close). Key news includes the University of Cambridge partnership center announcement and strategic ecosystem moves, but sentiment remains fragile under elevated volume.
(5) Price range justification & invalidation: Expecting continued distribution pressure over the remaining window toward multi-month support around $29.50, bounded above by resistance at $33.50. Strongest counter-evidence is strong dip-buying interest near $30.00 observed during the Oct 15 session low. A push and sustained hold above $34.50 accompanied by expanding buy volume would invalidate this bearish intraday momentum thesis.
(6) Confidence justification: 58% confidence reflects high short-term beta and volatile intraday ranges characteristic of speculative growth equities following structural breakdown below the 50-day moving average.
GPT-6
Result: right
View full reasoning
(1) Sources and conventions: IonQ (NYSE: IONQ) trades in USD. The historical and intraday reference is ChartExchange: https://chartexchange.com/symbol/nyse-ionq/historical/ . Historical figures represent regular-session daily OHLC and share volume, with sessions dated in America/New_York and ending at 16:00 ET. Prices are treated as split-adjusted OHLC, not dividend-adjusted total-return prices. Additional historical cross-check: https://stockanalysis.com/stocks/ionq/history/ . Vendors report somewhat different share-volume totals. ChartExchange is used consistently for the calculations below. The latest verified intraday quote precedes the authoritative forecast start by approximately 64 seconds; an exact start-time execution price is unavailable.
(2) Daily OHLCV - last five completed sessions, oldest to newest: session_date=2026-10-09, open=40.00, high=40.24, low=38.99, close=39.89, volume=13255800; session_date=2026-10-12, open=38.79, high=38.81, low=35.89, close=36.27, volume=32151500; session_date=2026-10-13, open=35.82, high=35.99, low=34.48, close=34.73, volume=23469233; session_date=2026-10-14, open=33.15, high=33.39, low=31.05, close=31.42, volume=41353668; session_date=2026-10-15, open=30.55, high=34.36, low=30.03, close=34.35, volume=48163347. These are completed daily bars only; October 16 is excluded. Source: https://chartexchange.com/symbol/nyse-ionq/historical/ .
(3) Twenty-session context: return_5d_pct=-12.93, calculated using the October 15 close of $34.35 and October 8 close of $39.45. For the 20 completed sessions from September 18 through October 15, high_20d=47.91, low_20d=30.03, and avg_volume_20d=27384557.4 shares. The October 14 and October 15 volumes were approximately 1.51 and 1.76 times this full-day average, respectively. October 15 produced a significant bullish reversal candle, recovering from $30.03 and closing just $0.01 beneath its session high. This provides genuine counter-evidence to the broader downtrend. Nevertheless, the five-session decline and repeated lower daily highs indicate that the prior bearish structure remains unresolved.
(4) Intraday evidence - PARTIAL SESSION, October 16: latest_price=31.75 USD; quote_time=2026-10-16T13:33:14-04:00; source=https://chartexchange.com/symbol/nyse-ionq/historical/ ; quote classification=regular-session market-open quotation, with independent feed-latency verification unavailable. At this observation, open=32.68, high_so_far=33.60, low_so_far=31.48, and cumulative_volume=15455448 shares. These are incomplete-session observations, not daily OHLCV. Intraday relative volume cannot be established without a verified same-time-of-day historical baseline. The price was down 7.57% from the October 15 close, showing that yesterday's powerful recovery had not produced sustained upward follow-through. No observations after 2026-10-16T17:34:18.100Z were incorporated.
(5) Event chronology and observed reaction: On October 12, IonQ announced an all-stock acquisition of cybersecurity company Elisity valued at up to $1.3 billion. On October 14, IonQ announced pricing of a $2.0 billion equity offering involving 20.5 million common shares, 29.5 million pre-funded warrants and additional warrants. The common shares and pre-funded warrants were priced at $40 each. Before the October 14 offering announcement, the October 13 regular-session closing price was $34.73. The change from that close to the October 16 observed quote is -8.58%. This is an observed multi-session change, not an isolated offering-related reaction: macro conditions, acquisition concerns and other market developments also contributed. Sources: https://www.reuters.com/legal/transactional/ionq-buy-cybersecurity-firm-elisity-up-13-billion-deal-2026-10-12/ and https://investors.ionq.com/news/news-details/2026/IonQ-Announces-Pricing-of-2-0-Billion-Equity-Offering/default.aspx .
(6) Catalyst assessment: The offering materially increases IonQ's prospective financial resources and strategic flexibility but also introduces dilution and potential future share-supply concerns. The Elisity acquisition expands IonQ's enterprise cybersecurity capabilities, although its immediate effect on profitability is uncertain. These announcements affect business expectations rather than representing sentiment alone. The stock's substantial decline indicates that investors have already incorporated considerable concern into the price, but the amount attributable specifically to dilution cannot be measured reliably. The possibility of further repricing remains. No company earnings release, product launch or other precisely scheduled IonQ catalyst during October 16-19 was independently verified. Additional company financing details or broader technology-sector news could nevertheless change sentiment.
(7) Market regime and technical synthesis: The prevailing regime is high-volatility bearish price discovery with intermittent sharp short-covering or relief rallies. The sequence from October 9 through October 14 established substantial downward momentum, while October 15's high-volume recovery created an initial reversal attempt. October 16 subsequently opened beneath the previous close and traded down to $31.48 before the documented quote, undermining immediate bullish continuation. The $30.03-$31.05 region is significant observed support from the October 14-15 lows. The $33.60-$34.36 region represents observed recent intraday and completed-session highs. Although the decline may be extended, an oversold condition alone does not establish a durable rebound.
(8) Forecast range and scored horizon: The authoritative forecast runs from 2026-10-16T17:34:18.100Z to 2026-10-19T17:34:18.100Z, spanning the remainder of Friday and Monday's morning and early-afternoon trading. From the $31.75 reference quotation, the projected absolute range is $28.20-$34.40, deliberately allowing more downside than upside. The recent daily ranges of approximately $1.51-$4.33 and the elevated event-driven volatility support a broad interval. A renewed test of $30.03 is plausible, with continuation below the recent lows potentially extending toward $28-$29. Conversely, stabilization and renewed demand could restore prices toward $33.60-$34.36. The central directional expectation is moderately negative, not a prediction that every intervening session will decline.
(9) Counter-evidence and invalidation: The strongest bearish counterargument is the October 15 recovery on 48.16 million shares, when price finished almost exactly at the day's high. The $40 offering price, above the prevailing market price, also provides a favorable financing interpretation that could support a rebound. A sustained future recovery above the verified October 15 high of $34.36, particularly alongside constructive company news, would substantially weaken the bearish thesis. Conversely, a future break beneath $30.03 with continued selling pressure would favor bearish continuation. These are observable analytical conditions, not trading instructions. The forecast concerns the move after the reference quote, not gains or losses already realized during the earlier decline.
(10) Confidence and limitations: Confidence is 57%, reflecting stronger recent downside momentum and the failure of the October 15 rebound to persist into the observed October 16 session. Confidence is limited by the violent reversal on October 15, unusual financing terms, substantial speculative sensitivity and uncertainty about broader market sentiment. The freshest verified quote is approximately one minute before the forecast baseline rather than precisely at it; therefore data_access is conservatively classified as partial. The range represents a probabilistic assessment rather than guaranteed price boundaries, and NEUTRAL remains a reasonable alternative if price stabilizes between the identified support and resistance areas.
DeepSeek
Result: right
View full reasoning
(1) What I found: As of 2026-10-16 17:34 UTC, Yahoo Finance (https://finance.yahoo.com/quote/IONQ/) shows IONQ trading at $31.76, down 7.54% from the prior close of $34.35, on the NYSE. The intraday session opened at $33.03, with a day's range of $31.47-$33.64 and volume of 15,497,465 shares, below the 20-day average of ~27.36M. The last five completed daily bars (Yahoo Finance, split-adjusted, USD, shares) are: 2026-10-09 O 40.00 H 40.24 L 38.99 C 39.89 V 13,255,800; 2026-10-12 O 38.79 H 38.81 L 35.89 C 36.27 V 32,151,500; 2026-10-13 O 35.82 H 35.99 L 34.48 C 34.73 V 23,468,100; 2026-10-14 O 33.15 H 33.39 L 31.05 C 31.42 V 41,353,700; 2026-10-15 O 30.55 H 34.36 L 30.03 C 34.35 V 47,713,286. Return over 5 sessions is -12.93% (latest close $34.35 vs. close five sessions earlier $39.45 on 2026-10-08). The 20-session high is $47.91 (2026-09-28) and the 20-session low is $30.03 (2026-10-15), with avg_volume_20d of 27,361,994 shares. Quote is live, regular-session, from Yahoo Finance.
(2) Market regime: IONQ is in a clear downtrend from the ~$44 area in late September, driven by the $2B equity offering priced at $40/share (announced 2026-10-14) and the $1.3B all-stock Elisity acquisition (announced 2026-10-12). The offering at $40, a premium to the then-market price, has not stemmed selling; the stock is down ~28% from its late-September levels. Quantum computing peers (Rigetti, D-Wave) have shown similar weakness. The regime is high-volatility, risk-off within the quantum sector.
(3) Price range: With the current price at $31.76 and the 20-day low at $30.03, I see the near-term floor around $29.00 if selling accelerates. The day's low of $31.47 and the $30.03 level are the first supports; a break below $30 opens $28-29. To the upside, the $33.64 intraday high and the $34.35 prior close cap near-term rallies. I set the range at $28.75-$33.50, skewed below the current price to reflect the negative catalyst overhang and below-average volume on today's decline.
(4) Catalysts: The $2B equity offering (priced at $40/share, 20.5M shares, announced 2026-10-14) is the dominant catalyst - it is massively dilutive (~4.8% share count increase) and signals the company's need for capital. The Elisity acquisition (all-stock, up to $1.3B) adds further dilution and integration risk. DARPA QBI Stage C (Oct 7) and the 1 kHz interconnect milestone (Oct 9) are positive but already reflected. Earnings on Nov 4, 2026, is outside the forecast window. No scheduled catalysts inside the window.
(5) Counter-argument: The strongest bullish case is that the $40 offering price is a ~26% premium to the current price, suggesting the institutional buyer (Heights Capital/Susquehanna affiliate) sees value. The Oct 15 bounce of +9.33% from a $30.03 low shows buyers defending $30. If the stock holds $30 and reclaims $33, the bearish thesis weakens. Invalidation: a close above $34.35 (prior close) or a sustained hold above $33.50 would undermine the bearish call. A break below $30.03 (20-day low) would confirm the downtrend.
(6) Confidence: 55%. The bearish catalyst (dilutive offering) and downtrend are clear, but the stock is highly volatile (beta 3.36) and has shown sharp intraday reversals. The offering price at $40 creates a potential magnet for price over time, which could support a bounce. Low confidence reflects the inherent noise in a 1-3 day window for a high-beta quantum name.
Read this comparison on ForecastNest, where it stays up to date if a score is ever recomputed.
Published automatically when this question settled, from shared research a member chose to make public. Content on ForecastNest Insights is for research, educational and informational purposes only. Nothing here is financial, investment, legal or tax advice, and nothing here is a recommendation to buy or sell anything.